Effectiveness of a Smoking Cessation Algorithm Integrated Into HIV Primary Care
To determine the efficacy of an algorithm designed to recommend smoking cessation-related pharmacotherapy options to the primary care providers of smokers living with HIV/AIDS.
Conditions:
🦠 HIV 🦠 AIDS 🦠 Smoking Cessation
🗓️ Study Start (Actual) 17 August 2020
🗓️ Primary Completion (Estimated) 1 March 2025
✅ Study Completion (Estimated) 1 March 2025
👥 Enrollment (Estimated) 600
🔬 Study Type INTERVENTIONAL
📊 Phase PHASE4
Locations:
📍 Birmingham, Alabama, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • 1. Enrollment in the CNICS clinical cohort.
    • 2. 18 years or older;
    • 3. Receiving HIV care at the UAB, UW or Fenway Health clinics and not anticipating changing clinics over the next six months
    • 4. Smoking greater than or equal to 5 cigarettes per day (cpd) for the past month
    • 5. Living in an unrestricted environment that allows smoking.

    Exclusion Criteria:

    • 1. Cognitive impairment such that unable to provide informed consent;
    • 2. Non-English speaking;
    • 3. Acutely suicidal, manic, acutely intoxicated, or otherwise not stable enough to provide informed consent;
    • 4. Currently receiving smoking cessation treatment.
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 5 September 2018
  • First Submitted that Met QC Criteria 11 September 2018
  • First Posted 13 September 2018

Study Record Updates

  • Last Update Submitted that Met QC Criteria 6 May 2024
  • Last Update Posted 8 May 2024
  • Last Verified May 2024